Negev Capital
Negev Capital primarily target companies with medications that are at early stage of clinical development.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Negev Capital Information
Geographic Data
Address: PO Box 309
City: Grand Cayman
State: other
Zip: KY1-1104
Country: KY
Financial Info
Stage:
Raised Last:
$0
Raised Total:$30M
Social
Twitter
Linkedin
Crunchbase
Metrics
3,481,094Website Global Rank
4,096Website Monthly Traffic
Twitter Followers
Description
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | Delix Therapeutics | Series A | 0 |
| 2/2022 | Mindstate Design Labs | Seed | 11.5M |
| 8/2021 | Beckley Psytech | Series B | 0 |
| 10/2022 | Psylo | Seed Round | 3.2M |
| 12/2022 | Gilgamesh Pharmaceuticals | Series B | 0 |
| 9/2021 | MycroDose Therapeutics | Seed Round | - |
| 6/2021 | Ocean Bio | Pre Seed Round | 0 |
| 6/2021 | NanoPsy | Seed Round | 0 |
| 2/2022 | Mindstate Design Labs | Seed Round | 0 |
| 9/2021 | Delix Therapeutics | Series A | 0 |
| 9/2021 | MycroDose Therapeutics | Seed Round | - |
| 8/2021 | Beckley Psytech | Series B | 0 |
| 6/2021 | NanoPsy | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
